709例感染性心内膜炎的外科治疗效果分析

Analysis of Surgical Treatment Outcomes in 709 Cases of Infective Endocarditis

  • 摘要: 目的 回顾单中心行外科治疗的感染性心内膜炎(infective endocarditis,IE)患者临床特征、短期预后及危险因素,总结治疗经验。方法 连续性纳入2012年5月至2024年6月因IE就诊于北京协和医院心外科并行手术治疗的患者,收集患者临床资料。分别对患者基线资料、合并症情况、IE易感因素、手术指征、病原体分布、手术方式、短期预后及其危险因素进行统计学分析。结果 共709例符合纳入和排除标准的IE患者入选本研究,85.3%累及左心瓣膜,中位年龄48.0(35.0,58.0)岁,68.0%为男性,8.7%为人工瓣膜感染心内膜炎,累及左心的IE患者合并症比例更高。43.2%的患者感染病原体为链球菌,右心IE感染金黄色葡萄球菌的比例更高,66.4%的患者存在心内结构异常的基础病因,32.7%的患者术前发生心力衰竭,90.1%的患者存在瓣膜功能障碍,11.3%的患者接受了急诊手术,24.8%的患者术前出现神经系统并发症。95.3%的主动脉瓣受累患者进行了瓣膜置换,二尖瓣受累患者瓣膜修复率达55.4%。院内死亡率为3.5%,院内复合不良事件发生率13.5%。术前NYHA心功能III~IV级(OR=5.24,95% CI : 2.01~13.71)、感染性三系减低(OR=3.32,95% CI :1.29~8.51)、区域性脑梗死(OR=4.09,95% CI : 1.34~12.49)、术前发热(OR=2.34,95% CI :1.00~5.47)是院内死亡的独立危险因素。年龄每增加10岁(OR=1.20,95% CI : 1.02~1.40)、金黄色葡萄球菌感染(OR=2.15,95% CI : 1.13~4.11)、术前生命体征不平稳(OR=2.29,95% CI : 1.26~4.17)、NYHA心功能III~IV级(OR=3.07,95% CI : 1.84~5.10)及既往心脏手术史(OR=2.10,95% CI : 1.12~3.96)是复合终点事件的独立危险因素。结论 左心IE与右心IE患者在病原体感染分布上存在明显差异,心力衰竭是手术治疗患者围术期死亡及不良预后的独立危险因素,通过严格把控手术时机、优化围术期管理,外科治疗或可有效降低IE患者的死亡率,改善患者预后。

     

    Abstract: Objective To review the clinical characteristics, short-term outcomes, and risk factors of patients with infective endocarditis (IE) who underwent surgical treatment at a single center, and to summarize treatment experience. Methods Consecutive patients diagnosed with IE who underwent cardiac surgery at the Department of Cardiac Surgery, Peking Union Medical College Hospital between May 2012 and June 2024 were enrolled. Statistical analyses were performed on their baseline characteristics, comorbidities, IE predisposing factors, surgical indications, pathogen distribution, surgical strategies, short-term outcomes, and associated risk factors. Results A total of 709 IE patients meeting the inclusion and exclusion criteria were included. IE involved left-sided valves in 85.3% of cases. The median age was 48.0 (35.0, 58.0) years, and 68.0% were male. Prosthetic valve endocarditis accounted for 8.7%. Patients with left-sided IE had a higher prevalence of comorbidities. Streptococcus was the causative pathogen in 43.2% of patients, while right-sided IE was more frequently associated with Staphylococcus aureus. Underlying structural heart abnormalities were present in 66.4% of patients. Preoperative heart failure occurred in 32.7% of patients, 90.1% had valvular dysfunction, 11.3% underwent emergency surgery, and 24.8% had preoperative neurological complications. Valve replacement was performed in 95.3% of patients with aortic valve involvement, whereas the mitral valve repair rate was 55.4%. The inhospital mortality rate was 3.5%, and the rate of in-hospital composite adverse events was 13.5%. Preoperative NYHA class III-IV (OR=5.24, 95% CI:2.01-13.71), infectious pancytopenia (OR=3.32, 95% CI:1.29-8.51), regional cerebral infarction (OR=4.09, 95% CI:1.34-12.49), and preoperative fever (OR=2.34, 95% CI:1.00-5.47) were identified as independent risk factors for in-hospital mortality. Every 10-year increase in age (OR=1.20, 95% CI:1.02-1.40), Staphylococcus aureus infection (OR=2.15, 95% CI:1.13-4.11), preoperative unstable vital signs (OR=2.29, 95% CI:1.26-4.17), NYHA class III-IV (OR=3.07, 95% CI:1.84-5.10), and history of prior cardiac surgery (OR=2.10, 95% CI:1.12-3.96) were independent risk factors for the composite endpoint event. Conclusions Significant differences in pathogen distribution were observed between patients with left-sided and right-sided IE. Heart failure was identified as an independent risk factor for both perioperative mortality and adverse outcomes in surgically treated patients. Through strict timing of surgical intervention and optimized perioperative management, surgical treatment may effectively reduce mortality and improve prognosis in patients with IE.

     

/

返回文章
返回